Psychometric Features of the Arabic Version of the Children's Communication Checklist (CCC2).

BACKGROUND

The Children's Communication Checklist-Second Edition (CCC-2) uniquely assesses overlooked communication elements such as pragmatics and context use, which are rarely addressed by conventional language assessments. This study focuses on the psychometric assessment of the CCC-2's Arabic version, tailored to evaluate communication challenges in Arabic-speaking children.

AIM

This study aims to validate the Arabic version of CCC-2 by testing its reliability and validity specifically for three higher-order constructs: Specific Language Impairment (SLI), Social Communication Disorder (SCD), and Impaired Behaviour within the Arabic-speaking population.

METHODS

A total of 121 participants in Saudi Arabia, showcasing diverse age and gender distributions, participated in the validation process. The study employed a Reflective-Reflective Higher-Order Construct (R-R HOC) model using partial least squares-structural equation modeling (PLS-SEM) to ensure content validity and cross-cultural adaptation of the translated items. Metrics such as Cronbach's alpha for reliability and Average Variance Extracted (AVE) for convergent validity were specifically examined.

RESULTS

The study confirmed the reliability and validity of the Arabic CCC-2, demonstrating robust psychometric properties, with Cronbach's alpha and AVE scores indicating satisfactory reliability and convergent validity across constructs. Structural model evaluation further supported the strong interrelations among the constructs of SLI, SCD, and Impaired Behaviour.

CONCLUSION

The results substantiate the Arabic CCC-2 as a reliable and valid tool for assessing communication challenges in Arabic-speaking children, particularly for diagnosing SLI, SCD, and Impaired Behaviour.

IMPLICATIONS

The validated Arabic CCC-2 has significant potential for application in clinical and educational settings and suggests directions for future research to explore its utility further in diverse clinical populations.